In experiments in which liver and testis freeze-stops were performed on pentobarbital-anaesthetized rats, ethanol (1.5 g/kg body wt.) reduced plasma testosterone concentration from 13.1 to 3.2 nmol/litre. 4-Methylpyrazole abolished the ethanolinduced hepatic and testicular increase in the lactate/pyruvate ratio, and the testicular acetaldehyde level, but did not diminish the reduction in plasma testosterone concentration. In testes, but not in liver, ethanol decreased the 3-hydroxybutyrate/ acetoacetate ratio, and 4-methylpyrazole did not prevent this effect. In experiments in which freeze-stop was performed after cervical dislocation, ethanol decreased the testis testosterone concentration from 590 to 220pmol per g wet wt. The effects of ethanol and 4-methylpyrazole on testis acetaldehyde, lactate/pyruvate and 3-hydroxybutyrate/ acetoacetate ratios were the same as found during anaesthesia. The NAD+-dependent ethanol oxidation capacity in testis ranged from 0.1 to 0.2,umol/min per g wet wt. and seemed to be inhibited by 4-methylpyrazole both in vivo and in vitro. In additional experiments, ethanol doses between 0.3 and 0.9g/kg body wt. did not alter the plasma testosterone concentration in rats treated, or not treated, with cyanamide, which induced elevated acetaldehyde levels in blood and testes. The results suggest that ethanol-induced inhibition of testosterone biosynthesis was not caused by extratesticular redox increases, or by extra-or intra-testicular acetaldehyde per se. The inhibition is accompanied by changes in testicular ketone-body metabolism.
Plasma testosterone concentration has been observed to become lower during acute ethanol intoxication in mice (Badr & Bartke, 1974; Badr et al., 1977 Badr et al., , 1979 , rats (Cicero & Badger, 1977; Cicero et al., 1978 Cicero et al., , 1979 Cicero et al., , 1981 Ellingboe & Varanelli, 1979) and humans (Rowe et al., 1974; Ylikahri et al., 1974; Dotson et al., 1975; Mendelson et al., 1977; Seto et al., 1978) . Inhibited testosterone biosynthesis during acute ethanol intoxication seems to be supported by several findings in vitro and in vivo. The data in vitro come from incubations of decapsulated mouse testes (Badr et al., 1977) , mouse (Yu et al., 1981) or rat (Ellingboe & Varanelli, 1979; Murono et al., 1980 ) Leydig-cell preparations, and from perfused rat testis (Cobb et al., 1980 (Cobb et al., , 1981 . The first observation in vivo suggesting inhibited testosterone biosynthesis was made by Badr et al. (1977) , who found that the testosterone concentration was lowered in the testes, in addition to plasma, during acute ethanol intoxication. This finding has been supported by rat studies, in which acute ethanol treatment inhibited human choriogonadotropin-stimulated testosterone production in vivo (Cicero et al., 1979; Ellingboe & Varanelli, 1979; Cicero et al., 1981) .
Inhibition of testosterone biosynthesis during ethanol intoxication could, in principle, be mediated directly, or indirectly, by extra-or intra-testicular ethanol in itself, or by its metabolism. Studies in vitro have varied in their estimates of the minimal ethanol concentrations needed to inhibit testosterone biosynthesis: >0.22mM (Murono et al., 1980) , > 10 mM (Cobb et al., 1981) , > 30 mM , >65mM (Ellingboe & Varanelli, 1979) , >650mM (Yu et al., 1981) and > 1.7M (Badr et al., 1977) . None of these studies guaranteed that the inhibitory effect was caused by ethanol in itself. In fact, the metabolism of ethanol, or more specifically ethanol-derived acetaldehyde (Badr et al., 1977; Cobb et al., 1978; , and ethanol-induced NAD+-deficiency (Ellingboe & Varanelli, 1979) , have been suggested as primary causes for the inhibition. The basis for these suggestions was provided by observations that acetaldehyde directly inhibited testosterone biosynthesis and that the addition of NAD+ reversed the ethanol-induced inhibition. The role of competition for NAD+ is also supported by a previous observation by Van Thiel et al. (1974) , who demonstrated that ethanol competitively inhibited the NAD+-dependent retinol oxidation in testis homogenates. In line with these considerations, Cicero et al. (1981) demonstrated in a recent study in vivo that pyrazole, which inhibits ethanol metabolism, decreased the ethanol-induced inhibition of testosterone production.
In the present study in vivo the role of acetaldehyde and ethanol-induced redox changes in testicular steroidogenesis was investigated by using the freeze-stop technique. To dissociate effects caused by ethanol itself from effects caused by its metabolism, 4-methylpyrazole, a rather specific and potent inhibitor of hepatic alcohol dehydrogenase (EC 1.1.1. 1; Reynier, 1969) , was used.
Materials and methods Rats
Male rats belonging to a 'mixed strain' developed by Eriksson & Rusi (1981) were used in the first series of liver freeze-stop experiments. Male LongEvans rats, bred in our laboratory (originating from rats purchased from Simonsen, Gilroy, CA, U.S.A.), were used in the other experiments. All animals were 2.5-3.5 months of age at the time of the experiments. Except for one series of experiments in which some animals received a special addition in the diet (see under 'General procedures'), the rats were given a standard laboratory diet (Astra-Ewos AB, Sodertalje, Sweden) and water ad lib. No ethanol had been previously given to the rats.
General procedures
All experiments were performed between 08.00h and 11.00h. In the first series of experiments animals were divided into three groups: a control group that received no injections, an ethanol-treated group injected intraperitoneally with 1.5 g of ethanol/kg body wt. as a 10% (w/v) solution in 0.9% NaCI, and a 4-methylpyrazole-plus-ethanoltreated group injected intraperitoneally with 10mg of 4-methylpyrazole/kg body wt. (Labkemi AB, Gothenburg, Sweden) as a 0.1% (w/v) solution in 0.9% NaCI 30min before the 1.5 g of ethanol/kg injection. Pentobarbital (Nembutal R; Abbot S. A., Brussels, Belgium) at 40mg/kg body wt. was injected intraperitoneally as a 1% (w/v) solution in 0.9% NaCl to all three groups of rats 1.75 h after ethanol administration. Tail blood samples were taken 2 h after ethanol administration. Immediately after blood sampling, one of the testes was frozen in situ by means of aluminium, clamps precooled in liquid N2. Immediately after this procedure part of the liver was freeze-clamped in situ. After liver freeze-stop an additional blood sample was taken by heart puncture.
In the second series of experiments a fourth group was added that received the 4-methylpyrazole but not the ethanol. Otherwise ethanol and 4-methylpyrazole treatments were the same as in the first series of experiments. No pentobarbital anaesthesia was, however, used. Instead, rats were cervically dislocated (2 h after ethanol administration) after the tail-blood sampling and one of the testes was quickly excised and freeze-clamped. Elapsed time between dislocation and freeze-stop was 13 s on average. The other testis was also excised (within 30 s) and freeze-stopped by rapid immersion in liquid N2.
In the third series of experiments rats were divided into two main groups, one receiving normal diet and one receiving cyanamide (as calcium carbimide; Dipsan R; Lederle Inc., Montreal, Que., Canada), a potent inhibitor in vivo of hepatic aldehyde dehydrogenase (EC 1.2.1.3) (Deitrich et al., 1976) , ground into the diet (0.2 g/kg of diet: equivalent to a daily consumption of about 9 mg/kg body wt.) for 5 days before the experiments. Ethanol doses of 0, 0.3, 0.6 and 0.9 g/kg body wt. were administered by gastric intubation as 10% (w/v) solution in 0.9% NaCl to both groups of rats. Tail blood samples were taken 0.5, 1 and 2 h after ethanol administration. After the last tail blood sample, rats were cervically dislocated and one of the testes was quickly excised and freeze-clamped. Additional blood samples were then taken by decapitation.
In addition to these main experiments, pilot tests in control animals compared the effects of 0.9% NaCl injections versus no treatment, and of freezeclamping versus direct immersion in liquid N2 (after dislocation).
Blood procedures
Tail blood was haemolysed with ice-cold water. The hemolysates were used directly for ethanol and acetaldehyde analyses. Blood taken by heartpuncture or after decapitation was centrifuged at 800g for 15min at 4°C. Plasma was removed and stored at -17°C for 4-5 weeks before testosterone analysis.
Freeze-stop procedures
The freeze-clamped livers and testes were pulverized in a mortar, and the tissue powder was suspended in ice-cold 0.6 M-HC104 shaken and the 1983 precipitate was centrifuged at 4000g for 15 min at 4°C. Supernatants were used for ethanol, acetaldehyde, lactate, pyruvate, acetoacetate and 3-hydroxybutyrate analyses. Thiourea (25 mM) (E. Merck AG, Darmstadt, Germany) was added to the supernatants used for determining liver and testis concentrations of ethanol and acetaldehyde. The testes obtained by immersion in liquid N2 were cut into two halves. One half of each testis was stored for 1-2 days at -17°C until alcohol and aldehyde dehydrogenase analyses. The other halves were stored for 6-7 weeks at -700C before testosterone analysis.
Metabolite measurements
Ethanol and acetaldehyde were measured with a Perkin-Elmer F40 gas chromatograph, using the head-space technique described by Eriksson et al. (1977) . This technique was also used for acetoacetate and 3-hydroxybutyrate, which were measured as acetone as previously described (Eriksson, 1972) . Lactate and pyruvate were assayed enzymically by a method described by Hohorst et al. (1959) . Enzymes and coenzymes were supplied by C. F. Boehringer, Mannheim, Germany.
Testosterone measurements
Plasma testosterone was measured as described (1978) . Briefly, testis pieces (about 100mg) were homogenized in water on ice and steroids were extracted with diethyl ether/ ethyl acetate. The organic phases were chromatographed on 1 ml Lipidex-5000 columns, and testosterone was quantified from the appropriate fraction by a specific radioimmunoassay system (Janne et al., 1974) . The recovery was monitored by inclusion of [3Hltestosterone into each sample, and samples with recovery of less than 85% were re-analysed. Hence no correction for recovery was needed. The interassay coefficient of variation for testosterone assay was monitored by inclusion of a known serum sample into each series of 15 testis samples, and found to be 1 1%.
Determination ofenzyme activities Testes were homogenized in 4 vol. of 0.25 Msucrose containing 1% (v/v) Triton X-100 (BDH Chemicals, Poole, Dorset, U.K.). The capacity of testis homogenates to utilize acetaldehyde in the presence of NAD+ was determined at 370C in 50mM-sodium/potassium phosphate buffer, pH7.4, supplemented with 4 mM-NAD+ and an initial acetaldehyde concentration of 0.75 mm. The reaction was started by addition of 0.3 ml of homogenate and the final volume was 3.2 ml. Samples (0.5 ml) were withdrawn at 2 min intervals, pipetted into serum bottles containing 3 M-HC1O4 (0.1 ml), and analysed for their acetaldehyde concentration by head-space gas chromatography (Eriksson et al., 1977) . Blanks with NAD+ omitted from the reaction mixture were subtracted from the results. Alcohol dehydrogenase activities were measured spectrophotometrically (366nm) in the soluble fraction of the homogenates (after 30min centrifugation at 3500Og at 40C). NADH production was determined at 370C in a buffer containing 74.7mM-semicarbazide, 74.7 mm-sodium pyrophosphate, 8.9 mM-glycine, pH 7.4, supplemented with 1.6 mM-NAD+, with or without 2.9 mM-4-methylpyrazole, and with (total activity) or without (endogenous activity) 14.3 mM-ethanol. The reaction was started by addition of 0.3 ml of supernatant and the final volume was 3.5 ml. Alcohol dehydrogenase activities were calculated by subtracting values obtained with 4-methylpyrazole present from values obtained without 4-methylpyrazole addition.
Statistical analyses
The results are given as means + S.D. Group mean comparisons were made with Student's t-distribution (Snedecor, 196 1) . Pearson r-coefficients (Senter, 1969) were used for correlation analyses.
Results
Effects of ethanol on plasma testosterone, and liver and testis metabolite concentration determined during anaesthesia
In the first series of experiments, the ethanol group showed a markedly decreased (P < 0.001) plasma testosterone concentration (3.2 + 2.4 nM; n = 22) relative to the controls (13.1 + 7.lnM; n = 10). 4-Methylpyrazole treatment did not prevent the ethanol-induced testosterone decrease (3.3 + 2.4 nM; n = 7). Pilot studies with control rats showed that the 0.9% NaCl injection alone had no effect on plasma testosterone concentration.
That 4-methylpyrazole at least partly inhibited ethanol metabolism is demonstrated in Table 1 . Higher ethanol and lower acetaldehyde concentrations were observed in the blood, liver and testes of the 4-methylpyrazole-plus-ethanol-treated rats compared with the ethanol-treated group. In fact, blood and testis acetaldehyde levels were not significantly different from zero after 4-methylpyrazole treatment. The average testis acetaldehyde concentration during normal ethanol oxidation was only 14% of the corresponding blood acetaldehyde concentration and about one-third (n = 7) of the individual testis acetaldehyde values were below the detection level (<2 nmol per g wet wt.).
Ethanol increased the hepatic redox (free NAD+/ free NADH) ratios in both the cytoplasm (indicated Vol. 210 Effect of ethanol on testicular testosterone and metabolite concentration determined after cervical dislocation The results obtained in the first series of experiments could, in theory, have been partially affected by the 15 min period of pentobarbital anaesthesia. Thus experiments were designed in which cervical dislocation followed by rapid freeze-stop were used. To check if 4-methylpyrazole had any effects of its own, an additional control group receiving only 4-methylpyrazole was included. In the pilot studies with control rats it was observed that the lactate/ pyruvate ratio tended to be higher in testes freezestopped by immersion in liquid N2 than in testes freeze-clamped directly (13 s) after dislocation. Thus only the testes obtained by direct freeze-clamping were used in the metabolite experiments.
Testicular testosterone concentrations are listed in Table 3 . In accord with the plasma changes seen in Vol. 210 the first series of experiments, ethanol markedly decreased the testicular testosterone concentration, and 4-methylpyrazole did not prevent this effect. Neither did 4-methylpyrazole alone have any effect on testosterone concentration.
4-Methylpyrazole plus ethanol treatment increased the ethanol concentration more than ethanol treatment alone in both blood (from 22.0+ 5.3 to 29.2+4.8mM, P<0.01) and in testes (Table 3 ). Significant acetaldehyde levels were not detected in blood or testes in any of the groups (in contrast with the previous experiments, in which pentobarbital anaesthesia was used).
As demonstrated in Table 3 , the testicular lactate/pyruvate ratio increased and 3-hydroxybutyrate/acetoacetate ratio decreased during ethanol oxidation, and 4-methylpyrazole blocked the former but not the latter effect (in accordance with the first series of experiments). 4-Methylpyrazole treatment alone had no significant effect on these redox metabolites. In these experiments no significant ethanol-induced increase of acetoacetate was observed in testes. The acetoacetate also did not correlate significantly with the testosterone concentration (control: r = -0.245; 4-methylpyrazole: r = -0.525; ethanol: r = 0.001; 4-methylpyrazole + ethanol: r = 0. 199).
The acetaldehyde elimination capacities are listed in Table 4 . No group differences were observed. Neither were any significant differences observed in the total alcohol dehydrogenase activities in the presence of a surplus of ethanol added in vitro (Table 4 ). The highest endogenous alcohol dehydrogenase activity was observed in the ethanoltreated group, which obviously was due to the remaining presence of a fraction (0.45 mM) of the ethanol in vivo. In spite of the same (or even higher) residue of ethanol in vivo also in the testis preparations from animals treated with 4-methylpyrazole plus ethanol, only low endogenous dehydrogenase activity was found in these preparations (Table 4) , which obviously was due to the presence of some 4-methylpyrazole (or derivative) left from the treatment in vivo.
Effect of elevated acetaldehyde on testosterone concentrations
To further test the hypothesis that acetaldehyde is the testicular toxin acting after ethanol ingestion, an additional series of experiments was designed. The idea was to test ethanol doses that in themselves would not lower the testosterone levels, together with an acetaldehyde concentration in vivo which was elevated as a result of cyanamide to such a degree that acetaldehyde would appear also in testes. The results are shown in Table 5 . No significant effects on plasma testosterone concentration were observed in any of the groups. There were no significant acetaldehyde concentrations observed in the testes or blood of the control animals receiving only the acute ethanol doses. In the cyanamide-treated rats an ethanol dose-dependent elevation in the acetaldehyde concentration was observed. With the highest ethanol dose (0.9 g/kg body wt.) acetaldehyde appeared also in the testes. Blood samples taken 30min after ethanol administration displayed blood acetaldehyde concentrations of 95 + 90 (ethanol dose: 0.3 g/kg body wt.), 207+75 (0.6 g/kg) and 226+ 119pUM (0.9g per kg body wt.). Since these blood acetaldehyde levels are much higher than those found 2 h after ethanol administration (Table  5) , it may be concluded that earlier during ethanol intoxication testis acetaldehyde had also been higher than after 2 h. In addition, it may be noted that the elevated acetaldehyde concentrations appeared in connection with a decreased rate of ethanol metabolism, as demonstrated by the elevated ethanol concentrations in the cyanamide groups (Table 5) .
Discussion
The present observation, that acute ethanol doses of 0.3-0.9g/kg body wt. did not reduce plasma testosterone concentration, and that the ethanol dose of 1.5 g/kg did reduce it, is in agreement with previous studies on rats (Cicero & Badger, 1977; Cicero et al., 1978 Cicero et al., , 1979 Cicero et al., , 1981 Ellingboe & Varanelli, 1979) . However, we did not observe the increased testosterone concentration after a lower (0.75g/kg) ethanol dose, as reported by Cicero & Badger (1977) and Cicero et al. (1978) . Mice seem to be more sensitive than rats to this effect of ethanol, since doses of only 0.16-1.24 g/kg body wt.
have been reported to decrease their plasma testosterone concentration (Badr & Bartke, 1974) ; the reason for their greater sensitivity is unknown. The reason for the conflicting results regarding human testosterone concentration during acute ethanol intoxication in non-alcoholic subjects is also unknown [a decrease has been reported by Rowe et al. (1974) , Ylikahri et al. (1974) , Mendelson et al. (1977) and Seto et al. (1978) , no change by Toro et al. (1973) , Ylikahri et al. (1978) and Linnoila et al. (1980) and a biphasic effect by Dotson et al. (1975) ].
The present results regarding ethanol-induced decreased testosterone concentrations in freezestopped testes seem to eliminate increased hepatic metabolism, increased peripheral uptake and inhibited secretion from the testes as being the principal causes for decreased plasma testosterone concentration. Instead, inhibited testicular testosterone biosynthesis seems to be the main cause for the testosterone reduction. No previous reports have been published about rat testis testosterone concentration during acute ethanol intoxication. Our data are in accord with those from a previous study on mice, in which an additional ethanol dose (after 4 1983 (Badr et al., 1977 ).
The conclusion from several studies in vitro, in which acetaldehyde concentrations of 100mM (Badr et al., 1977) , 100puM and 5O,UM Two previous studies, one in vitro (Cobb et al., 1978) and one in vivo (Cicero et al., 1981) , report that pyrazole (in vivo) and 4-methylpyrazole (in vitro) attenuate the ethanol-induced inhibition of testosterone biosynthesis. The present results in vivo, in which 4-methylpyrazole did not prevent the lowering of plasma or testis testosterone concentration, do not support the previous findings. One possible explanation may be that both Cobb et al. (1978) and Cicero et al. (1981) investigated human choriogonadotropin-stimulated steroidogenesis. Thus the highly increased testosterone biosynthesis may have become sensitized to competitive inhibition by testicular ethanol metabolism. Another possibility would, in principle, be that our 4-methylpyrazole treatment, although inhibiting hepatic ethanol metabolism, did not inhibit testicular ethanol metabolism enough to prevent some mechanism other than acetaldehyde [such as increased NADH/ NAD+ ratio (Ellingboe & Varanelli, 1979) 1 from inhibiting testosterone biosynthesis. This possibility is, however, not supported by the efficient inhibition of endogenous ethanol-dependent NADH formation in testis preparations from the 4-methylpyrazoletreated animals (Table 4) . It is not known, however, to what extent, if at all, the measured alcohol dehydrogenase activity represented the functional enzyme activity responsible for possible ethanol metabolism in the Leydig cells. In this connection it should be noted that pyrazole-sensitive alcohol dehydrogenase activity has been previously observed in testis (Erwin & Deitrich, 1972) and that in a Vol. 210 preliminary communication it has been reported that testicular alcohol dehydrogenase activity may be confined to the interstitial cells (Messiha et al., 1980) . That 4-methylpyrazole treatment blocked the ethanol-induced increase in testicular lactate/ pyruvate ratio also argues against the role of an increased NADH/NAD+ ratio being responsible for the inhibition of the stereoidogenesis. On the other hand, there is no evidence that the whole-testis lactate/pyruvate ratio really represents the functional free NADH/free NAD+ ratio at the site of the steroidogenesis, rather than merely being a reflection of the corresponding hepatic redox change (as supported by the correlation between hepatic and testicular lactate/pyruvate ratio during ethanol intoxication).
The shift to a lower testicular 3-hydroxybutyrate/ acetoacetate ratio during ethanol intoxication is difficult to understand. Nothing is known about the intratesticular localization and functional activity of 3-hydroxybutyrate dehydrogenase (EC 1.1.1.30). Neither is it known whether testicular ketone bodies may serve as precursors for steroidogenesis. In theory, it could be possible for testicular acetoacetate to become activated and enter the cholesterol pathway leading to pregnenolone and testosterone synthesis in testis. If this were true, the decreased total ketone-body concentration in testis during ethanol intoxication (with and without 4-methylpyrazole) may have contributed to decreased testosterone production. This argument is supported by the positive correlation (significant in the first series of experiments) between testicular acetoacetate and plasma testosterone concentration during ethanol oxidation. Whether there is a meaningful relationship between decreased testosterone biosynthesis and the ketone-body changes during ethanol intoxication is not clear from the present investigation, but may prove to be a challenging target for further investigations.
